Q（Question）

Is it correct to understand that Medical Representatives (MRs) may also provide information on unapproved drugs and off-label drugs?

A（MHLW answer）

The provision of information on unapproved drugs, off-label drugs, and similar products is intended to be separated from ordinary promotional information activities, and since scientific and professional validity is particularly required, it is preferable for someone other than the ordinary promotional activity representative—someone in a position to respond appropriately—to handle such inquiries. However, this does not preclude an MR from handling such inquiries in an environment separated from ordinary promotional information activities, provided that all of the conditions set out in items (1) through (8) of Part 4, Section 3 of the Guidelines are met.

So what (meaning): MR involvement is not categorically prohibited, but it is permissible only in an environment physically and organizationally separated from normal MR activities, and only when every one of the eight conditions in Part 4, Section 3 is satisfied. Failure to meet even one condition makes MR provision impermissible.

So why (rationale): Unapproved and off-label information carries high scientific complexity, and incorrect information can cause direct patient harm; the Guidelines therefore exclude this from the normal promotional framework as the default position.

Commentary — background, application, practical notes

This Q&A, which indicates that MR provision of unapproved or off-label information is 'not categorically prohibited,' simultaneously sets a high bar by making clear that it is not easily permitted. Each of the eight conditions in Part 4, Section 3 (1)-(8) of the Guidelines is an independent necessary condition; the failure of any one makes MR provision impermissible. Interpreting this Q&A as 'MRs can do it' is an error; the operational design must be oriented toward 'possible only under extremely limited conditions.'

A typical scenario arises in rare or highly specialized disease areas where Medical Affairs specialist personnel are scarce and MRs must convey scientific information to physicians. Even in such cases, the MR must provide the information in a separate setting and time completely isolated from normal visit activities; providing unapproved or off-label information as an extension of a normal MR visit is not permitted. Additionally, verification of and documentation for all eight conditions must occur before and after each such provision, and the internal procedural design to ensure this must be established in advance.

The most common boundary error is omitting verification of the eight conditions on the grounds that 'the physician strongly requested it' or 'the information was absolutely necessary for patient treatment.' Information provided without satisfying all conditions constitutes a guideline violation even if it responds to a physician's strong request. Furthermore, the interpretation of 'an environment separated from ordinary activities' requires not only physical separation (a different room, a different visit, etc.) but also organizational and documentary separation; a situation where 'the topic shifted during the same visit' does not constitute a proper separation.